JAMES M. FRATES

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES M. FRATES:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Common Stock 280K $4.11M $14.65 30 Sep 2025 Direct
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Common Stock 11.1K $109K $9.84 30 Sep 2025 By Trust
Sage Therapeutics, Inc. Director Common Stock 0 $0 $7.79 31 Jul 2025 Direct
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 103K 06 Mar 2025 Direct
Sage Therapeutics, Inc. Director Stock Options (Right to buy) 19.2K 03 Jan 2025 Direct
Sage Therapeutics, Inc. Director Stock Option (Right to Buy) 0 31 Jul 2025 Direct

Insider Reports Filed by JAMES M. FRATES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 30 Sep 2025 1 -$155K 4 Chief Financial Officer 02 Oct 2025, 16:15
SAGE Sage Therapeutics, Inc. 31 Jul 2025 3 $0 4 Director 31 Jul 2025, 11:28
SAGE Sage Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:13
AMLX Amylyx Pharmaceuticals, Inc. 31 Mar 2025 1 -$37.8K 4 Chief Financial Officer 02 Apr 2025, 17:22
AMLX Amylyx Pharmaceuticals, Inc. 06 Mar 2025 2 $0 4 Chief Financial Officer 10 Mar 2025, 20:28
SAGE Sage Therapeutics, Inc. 03 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:02
AMLX Amylyx Pharmaceuticals, Inc. 12 Sep 2024 1 $101K 4 Chief Financial Officer 16 Sep 2024, 17:30
SAGE Sage Therapeutics, Inc. 10 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:58
AMLX Amylyx Pharmaceuticals, Inc. 16 Apr 2024 2 $0 4 Chief Financial Officer 18 Apr 2024, 20:23
AMLX Amylyx Pharmaceuticals, Inc. 05 Mar 2024 1 -$33.6K 4 Chief Financial Officer 07 Mar 2024, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 26 Feb 2024 2 $0 4 Chief Financial Officer 28 Feb 2024, 18:44
AMLX Amylyx Pharmaceuticals, Inc. 09 Jan 2024 1 -$44.3K 4 Chief Financial Officer 11 Jan 2024, 17:11
SAGE Sage Therapeutics, Inc. 03 Jan 2024 1 $0 4 Director 04 Jan 2024, 16:07
AMLX Amylyx Pharmaceuticals, Inc. 31 Oct 2023 1 $0 4 Chief Financial Officer 02 Nov 2023, 15:33
AMLX Amylyx Pharmaceuticals, Inc. 23 Aug 2023 2 $125K 4/A Chief Financial Officer 05 Sep 2024, 19:55
SAGE Sage Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:06
AMLX Amylyx Pharmaceuticals, Inc. 16 May 2023 4 -$652K 4 Chief Financial Officer 18 May 2023, 20:54
AMLX Amylyx Pharmaceuticals, Inc. 16 Mar 2023 6 -$813K 4/A Chief Financial Officer 24 Mar 2023, 18:48
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2023 2 $96.5K 4 Chief Financial Officer 10 Jan 2023, 18:20
AMLX Amylyx Pharmaceuticals, Inc. 30 Dec 2022 2 $34.4K 4 Chief Financial Officer 04 Jan 2023, 20:33
SAGE Sage Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:36
AMLX Amylyx Pharmaceuticals, Inc. 11 Feb 2022 1 $0 4 Chief Financial Officer 28 Mar 2022, 16:30
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 2 $0 4/A Chief Financial Officer 26 Apr 2023, 19:34
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3/A Chief Financial Officer 26 Apr 2023, 19:30
SAGE Sage Therapeutics, Inc. 16 Jun 2021 1 $99.7K 4 Director 17 Jun 2021, 16:04
SAGE Sage Therapeutics, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:11